mTORC1 signaling and regulation of pancreatic β-cell mass

Citations Over TimeTop 10% of 2012 papers

Abstract

The capacity of β cells to expand in response to insulin resistance is a critical factor in the development of type 2 diabetes. Proliferation of β cells is a major component for these adaptive responses in animal models. The extracellular signals responsible for β-cell expansion include growth factors, such as insulin, and nutrients, such as glucose and amino acids. AKT activation is one of the important components linking growth signals to the regulation of β-cell expansion. Downstream of AKT, tuberous sclerosis complex 1 and 2 (TSC1/2) and mechanistic target of rapamycin complex 1 (mTORC1) signaling have emerged as prime candidates in this process, because they integrate signals from growth factors and nutrients. Recent studies demonstrate the importance of mTORC1 signaling in β cells. This review will discuss recent advances in the understanding of how this pathway regulates β-cell mass and present data on the role of TSC1 in modulation of β-cell mass. Herein, we also demonstrate that deletion of Tsc1 in pancreatic β cells results in improved glucose tolerance, hyperinsulinemia and expansion of β-cell mass that persists with aging.

Related Papers

• → Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins(2003)929 cited
• → Rheb fills a GAP between TSC and TOR(2003)490 cited
• → Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways(2005)385 cited
• → Rhebbing up mTOR: New Insights on TSC1 and TSC2, and the Pathogenesis of Tuberous Sclerosis(2003)384 cited
• → Measurements of TSC2 GAP Activity Toward Rheb(2006)20 cited